开窗或分支腔内主动脉修复术后瘤囊回缩与长期生存改善相关
本研究基于美国10项医生发起的IDE研究,分析2005至2023年因近肾、肾上或1-5型胸腹主动脉瘤行择期FB-EVAR且有30天和1年CT随访的1497例患者。1年时6.9%患者瘤囊扩大、46.4%回缩、46.7%稳定;瘤囊扩大和稳定均与长期生存率降低相关。
要点
- FB-EVAR术后1年瘤囊扩大、稳定和回缩分别占6.9%、46.7%和46.4%。
- 1年瘤囊扩大与5年生存率降低相关(48.1% vs 回缩组67.7%)。
- 1年瘤囊稳定亦与长期死亡率升高相关(HR 1.26)。
核心结论
- FB-EVAR术后1年瘤囊扩大和稳定(未回缩)均与长期生存率降低相关,而瘤囊回缩者生存更优。
研究设计与样本
- 分析美国10项医生发起的IDE研究中2005至2023年行择期FB-EVAR的1497例患者,中位随访2.9年(IQR 1.3-4.0年)。
主要发现
- 1年时103例(6.9%)瘤囊扩大,694例(46.4%)回缩,700例(46.7%)稳定。
- 瘤囊扩大的独立预测因素包括年龄(OR 1.04)、既往主动脉手术(OR 2.22)、既往EVAR(OR 1.84)、较大动脉瘤直径(OR 1.03)、30天CT发现II型内漏(OR 2.15)及第一年任何二次干预(OR 2.19)。
- 1年总生存率:扩大组85.6% vs 稳定组90.9% vs 回缩组93.1%;5年总生存率:扩大组48.1% vs 稳定组63.0% vs 回缩组67.7%。
- 未调整Cox模型中,与回缩组相比,扩大组HR 2.083(95%CI 1.47-2.95,P<.0001),稳定组HR 1.26(95%CI 1.02-1.56,P=.0298)。
关键数值与推荐
- 瘤囊回缩或扩大(≥5 mm)依据SVS指南定义。
临床怎么用
- FB-EVAR术后需警惕瘤囊扩大和稳定(未回缩),因其与长期生存率降低相关。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aneurysm sac behavior after fenestrated or branched endovascular repair (FB-EVAR) of thoracoabdominal aortic aneurysms (TAAAs) remains a key knowledge gap. The purpose of this study was to identify independent predictors of sac behavior after FB-EVAR and assess the relationship between sac behavior and long-term survival. METHODS: Patients undergoing FB-EVAR between 2005 and 2023, in 10 physician-sponsored investigational device exemption studies in the United States, were analyzed. Patients who underwent elective FB-EVAR for juxtarenal, suprarenal, or extent 1 to 5 TAAAs and had 30-day and 1-year computed tomography follow-up imaging were included. Patients with chronic aortic dissections were excluded. Sac regression or expansion (≥5 mm) was defined using the Society for Vascular Surgery guidelines. Independent predictors of sac growth were identified using multivariable logistic regression analysis and survival rates were compared using Kaplan-Meier curves. RESULTS: Of 3057 patients who underwent FB-EVAR, 1497 were eligible for analysis. Median follow-up was 2.9 years (interquartile range, 1.3-4.0 years). At 1 year, 103 (6.9%) patients experienced sac expansion, 694 (46.4%) experienced sac regression, and 700 (46.7%) had a stable sac. Variables independently associated with sac expansion were age (odds ratio [OR] 1.04; 95% confidence interval [CI], 1.01-1.07; P = .0057), prior aortic surgery (OR, 2.22; 95% CI, 1.32-3.40; P = .0026), prior EVAR (OR, 1.84; 95% CI, 1.07-3.14; P = .0264), larger aneurysm diameter (OR, 1.03; 95% CI, 1.01-1.04; P = .0014), type II endoleak observed on 30-day follow-up computed tomography (OR, 2.15; 95% CI, 1.36-3.41; P = .0011), and any secondary intervention during the first year (OR, 2.19; 95% CI, 1.35-3.55; P = .0016). Overall survival at 1 year was significantly lower in the expansion group compared with the stable and regression groups (85.6% vs 90.9% vs 93.1%, respectively). This effect persisted on 5-year evaluation (48.1% vs 63.0% vs 67.7%, respectively). Both expansion and stability at 1 year were both associated with increased long-term mortality in unadjusted cox model (expansion, hazard ratio, 2.083; 95% CI, 1.47-2.95; P < .0001; stability, hazard ratio, 1.26; 95% CI, 1.02-1.56; P = .0298) vs regression. CONCLUSIONS: Both aneurysm sac expansion and stability (lack of regression) one year after FB-EVAR are associated with decreased long-term survival compared with sac regression. These outcomes underscore the need for vigilant monitoring of patients without sac regression and to better understand if interventions to address factors associated with unfavorable aneurysm sac behavior can improve long-term survival.
引用
- Zehner K, Zack J, Schanzer A, et al. Aneurysm sac regression after fenestrated or branched endovascular aortic repair is associated with superior long-term survival. J Vasc Surg. 2025. PMID: 40449698. doi:10.1016/j.jvs.2025.05.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。